⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MPLT News
MapLight Therapeutics, Inc. Common Stock
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
MPLT
MapLight Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
MPLT
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
globenewswire.com
MPLT
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
globenewswire.com
MPLT
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies
globenewswire.com
MPLT
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
globenewswire.com
MPLT